Amenorrhea secondary to vismodegib: An adverse event to consider especially in female patients with Gorlin‐Goltz syndrome-Reference-Cited by-同舟云学术

Amenorrhea secondary to vismodegib: An adverse event to consider especially in female patients with Gorlin‐Goltz syndrome

Published:2020-05-26 Issue:4 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Russo Filomena¹^ORCID,Provvidenziale Luca¹,Mancini Virginia²,Lazzeri Laura¹,Flori Maria Laura¹,Taddeucci Paolo¹,Rubegni Pietro¹

Affiliation:

1. Department of Medical, Surgical and Neurological Science, Dermatology Section University of Siena, S. Maria alle Scotte Hospital Siena Italy

2. Pathology Section, Department of Medical Biotechnology University of Siena Siena Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13527

Reference8 articles.

1. Emerging concepts and recent advances in basal cell carcinoma;Totonchy M;F1000Res,2017

2. Long‐term response to vismodegib in a patient with Gorlin‐Goltz syndrome: a case report and review of pathological mechanisms involved;Kesireddy M;Cureus,2019

3. Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS)

4. Amenorrhea secondary to a vismodegib-induced blockade of follicle-stimulating hormone–receptor activation

5. Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies;American Journal of Clinical Dermatology;2024-06-19

2. Vismodegib in Gorlin‐Goltz syndrome: A systematic review;Australasian Journal of Dermatology;2024-06-12

3. Radiological evaluation of odontogenic keratocysts in patients with nevoid basal cell carcinoma syndrome: A review;The Saudi Dental Journal;2023-09

4. Long‐term efficacy of a Vismodegib regime including a 1‐week drug holiday every month in two patients with Gorlin Goltz syndrome;Dermatologic Therapy;2022-01-04

5. Vismodegib;Reactions Weekly;2020-10